|
FR2803203A1
|
|
New galenic formulations of fenofibrate
|
|
FR2802929A1
|
|
Benzophenone alpha-d-glycopyranosides, preparation and use in therapeutics
|
|
FR2802930A1
|
|
Benzophenone glycopyranosides, preparation and use in therapeutics
|
|
FR2801886A1
|
|
Chiral ligands and catalysts especially useful for asymmetric hydrogenation
|
|
FR2801585A1
|
|
New ii-8 receptor antagonists
|
|
FR2801055A1
|
|
Beta-d-5-thioxylose derivatives, preparation method and therapeutic use
|
|
US6291433B1
|
|
Derivatives of α-D-Thioxyloside and their use against atheroma
|
|
CN1305486A
|
|
Novel compounds derived from alpha-D-xylose, preparation method and therapeutic use
|
|
CZ20004845A3
|
|
Compounds derived from alpha-D-xylose, process of their preparation, pharmaceutical preparation and therapeutic use
|
|
FR2790260A1
|
|
Novel n- (benzenesulfonamide) compounds, method of preparation and therapeutic use
|
|
FR2772027A1
|
|
Process for the asymmetric preparation of 2-mercaptomethyl-3-phenyl-propanoic acid derivatives, use for synthesis of active chiral principles
|
|
FR2765222A1
|
|
Novel n-benzenesulfonyl-l-proline compounds, method of preparation and therapeutic use
|
|
FR2756566A1
|
|
Bradykinin b2 receptor agonist peptides, method of preparation and use in therapeutics
|
|
FR2756562A1
|
|
Novel n-benzenesulfonyl-l-proline compounds, method of preparation and therapeutic use
|
|
FR2751650A1
|
|
Novel n-benzenesulfonyl-l-proline compounds, method of preparation and therapeutic use
|
|
CA2187281A1
|
|
15-deoxyspergualin analogs, their use in therapeutics and their method of preparation
|
|
FR2743073A1
|
|
Novel 1-benzenesulfonylpyrrolidine compounds, method of preparation and therapeutic use
|
|
FR2737891A1
|
|
15-deoxyspergualin chiral analogs, preparation method and therapeutic use
|
|
FR2737892A1
|
|
Novel benzenesulfonamide compounds, preparation method and therapeutic use
|
|
FR2735128A1
|
|
Novel benzenesulfonamide compounds, process for their preparation and therapeutic use.
|
